Depending on the jurisdiction, companies selling cannabis-derived products may need to comply with pathogen testing to protect consumers from harmful microorganisms, including Aspergillus spp.
Previous biofoundry efforts have produced a wide variety of products such as chemicals, fuels, and engineered cells and proteins, but those studies were not performed in a fully automated manner
Once cell lines are finally validated, why jeopardize your results with cheap and low-end detection kits that can impact the reproducibility of your experiments?